Gait Disorders in Parkinson's Disease: Assessment and Management  by Chen, Pei-Hao et al.
at SciVerse ScienceDirect
International Journal of Gerontology 7 (2013) 189e193Contents lists availableInternational Journal of Gerontology
journal homepage: www.i jge-onl ine.comReview ArticleGait Disorders in Parkinson’s Disease: Assessment and Managementq
Pei-Hao Chen 1,3,4, Rong-Long Wang 2, De-Jyun Liou 2, Jin-Siang Shaw2*
1Graduate Institute of Mechanical and Electrical Engineering, 2 Institute of Mechatronic Engineering, National Taipei University of Technology, 3Department
of Neurology, Mackay Memorial Hospital, 4Mackay Medicine, Nursing and Management College, Taipei, Taiwana r t i c l e i n f o
Article history:
Received 14 October 2012
Received in revised form
20 January 2013
Accepted 8 March 2013






kineticsq The authors have no conﬂicts of interest relevant
* Correspondence to: Dr Jin-Siang Shaw, Institute o
National Taipei University of Technology, Number 1,
Road, Taipei 10608, Taiwan.
E-mail address: jshaw@ntut.edu.tw (J.-S. Shaw).
1873-9598/$ e see front matter Copyright  2013, Ta
http://dx.doi.org/10.1016/j.ijge.2013.03.005s u m m a r y
Gait disorder, a major cause of morbidity in the elderly population, is one of the cardinal features of
Parkinson’s disease. Owing to the characteristics of these gaits varying widely from festination to
freezing of gait, analysis can be hardly identiﬁed in the clinical setting. Instrumented gait analysis has
been widely used in a traditional gait laboratory. Recently, wireless monitoring systems have become
highly informative by allowing long-term data collection in a variety of environments outside the labs.
The quantitative analysis of gait patterns is probably the ﬁrst step to a successful management of an
individual patient. The presence of abnormal gait usually indicates advanced stages of disease and is
often associated with cognitive impairment, falls, and injuries. Besides pharmacological and surgical
treatments, parkinsonian gait can beneﬁt from a variety of interventions. Assistive devices prevent
patients from falls, and cueing strategies help them decrease episodes of freezing. Therefore, a multi-
disciplinary team approach to the optimal management is essential for an elderly patient with Parkin-
son’s disease.
Copyright  2013, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Parkinson’s disease (PD) is the second most common neurode-
generative disorder, affecting about 1% of adults over 60 years of
age1. This ﬁgure increases from 3% to 5% in people aged above 85
years2. The prevalence rate of PD in Taiwan is similar to that re-
ported in Western countries, and in the areas studied, and the
incidence was twice as high in the urban area as in the rural area3.
Primary features include resting tremor, rigidity, bradykinesia, and
loss of postural reﬂexes. Progressive loss of postural reﬂexes
eventually develops in most patients with PD, leading to gait dif-
ﬁculties and balance problems. Typical gait disorders of PD include
stooped posture, freezing of gait (FOG), festination, shufﬂing steps,
and falling. FOG, deﬁned as an episodic inability to generate
effective steps in the absence of any known cause other than
parkinsonism or high level gait disorders, is most commonly
experienced during step initiation and turning but also when faced
with obstacles, doorways, stress, and distraction4. The FOGto this article.
f Mechatronics Engineering,
Section 3, Chung-Hsiao East
iwan Society of Geriatric Emergenphenomenon is believed to be related to lesions in the striatum, the
frontal lobe, and frontal basal ganglia projections. It is estimated to
affect around 7% of people with early disease and 60% of people
with advanced disease, leading to impairment of quality of life,
mobility, and independence5. In this article, we determine the
current status of laboratory-based gait-analysis technology, intro-
duce gait analysis using wireless sensors, review the current evi-
dence on gait analysis of patients with PD, and provide a
comprehensive outlook for the treatment of gait disorders in pa-
tients with PD.
Effective treatment, speciﬁcally for gait disturbance in PD, re-
quires reliable tools for determination of the severity of gait dis-
orders and assessment of the efﬁcacy of interventions. At the
present time, instrumented gait analysis is carried out primarily in
one of two ways6. The ﬁrst method is performed in a standard gait
laboratory by using specialized technology with full analysis of the
motion of all body segments and is expensive and requires
cumbersome equipment to be attached to the patient; however,
this method produces well-quantiﬁed and accurate results over
short distances. The second method is newly developed and uses
wearable sensors with a long-term monitoring system; the
equipment involved is light, small, and inexpensive and can be
carried for long periods and distances to quantify gait parameters
(Table 1).cy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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Human gait analysis can be divided into three ﬁelds: kinematics,
kinetics, and electromyography (EMG). The kinematics of the hu-
man gait records the movements of the major joints of the lower
extremity in the human gait. Gait kinetics highlights the study of
forces and actions involved in the production of humanmovements
and often requires the orientation of all the leg segments obtained
from gait kinematics. The EMG of the human gait focuses on
detecting and analyzing muscle activity during walking.
A standard gait laboratory, usually located in a hospital or a
research center, will usually have four systems for evaluating gait:
 A video system, which records images of the patient while
walking.
 A motion-capture system, which digitally tracks the patient’s
movements.
 Force plates, which are used to measure ground-reaction force.
 An EMG system, which is used to record muscle activity during
gait.
Video recordings are used to augment observational gait anal-
ysis and provide a degree of quality control of the motion-capture
data. Slow-motion and even frame-by-frame playback can be
used as an adjunct to observational gait analysis, enabling quick or
subtle movements to be more readily detected. Viewing the patient
from multiple angles simultaneously can also be helpful in under-
standing the patient’s movement patterns. Basic gait parameters,
including cadence, stride length, and speed, can be obtained from a
video recording of the subject walking across a known distance
bounded by two adhesive tape lines on the ﬂoor.
The current clinical solution for motion sensing is to use a
camera-based optical motion-capture system, which consists of
synchronized cameras, markers attached to the patient’s body, and
computer software that acquires marker motion during walking.
The marker position data are highly accurate and can be used for
further kinematic and kinetic analysis of human gait. Although
effective, this technique is time consuming and expensive.
Force plates measure the force applied to the ground by the feet
as the patient walks over them. They measure not only the
downward force exerted by a person while walking, but also the
braking and acceleration force and force directed mediolaterally.
The number of force plates varies according to the laboratory. In-
formation is then integrated with the motion-capture system to
assess the mechanics of the movement. Treadmills can be used toTable 1
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Inertial sensors consisting of either
accelerometers, gyroscopes or a
combination, attached to parts of
the body, which are linked to a tiny
computer capable of recording data
and online signal processing
1. Portable, low-cost a
2. Good at measuring
3. Suitable for measur
4. Can be used indoor
lighting conditions
5. Continuously moni
of timeallow gait to be observed for longer times and at higher speeds than
can be achieved on a gait laboratory walkway. Equipping treadmills
with force sensors and high-speed cameras to capture details
invisible to the naked eye may permit the analysis of both the ki-
nematics and kinetics of gait.
The EMG system is used to track the activities of muscles during
gait, a process referred to as “dynamic EMG”. The analysis of EMG
can be done on several levels. Themost basic level determines if the
activity of a muscle is phasic, with clear on and off periods, or is
nearly constant, either on or off, indicating an absence of useful
control. The next level of analysis determines if the timing and
intensity of the EMG during a phase of or the entire gait cycle in-
forms neurological control and muscle integration. If the patient’s
posture or movement dynamics are abnormal, it follows that the
mechanics of movement will be altered; hence, the activity of the
muscle driving that movement will also be altered. Muscle activity
can be effectively assessed only in conjunction with a motion-
capture system or force-plate data.
A lengthy hospital stay in order to monitor and adjust a pa-
tient’s treatment contributes to increased costs and morbidity
because of the hospitalization itself. Another disadvantage of the
standard gait laboratory method is that the monitoring process is
carried out in a controlled environment in which the patient feels
safe. Many patients experience the most severe episodes of
freezing gait while at home, possibly because of distraction or
inattention to walking.
3. Gait analysis using wireless sensors
Recent advances in gait analysis include portable digital moni-
toring systems, data gathering by the patients themselves, and
wearing sensors both in and outside the home. Portable technology
may be more suitable than complex and time-consuming labora-
tory-based methods. This option is supported by a rapidly
increasing body of literature reporting the successful detection of
gait disturbances in individuals through the use of relatively low-
cost, portable devices that can be widely applied. Examples
include the application of body-ﬁxed sensors (e.g., accelerometers,
gyroscopes) to further quantify gait parameters.
An accelerometer is the most common type of inertial sensor.
Its ability to measure changes in speed along its sensitive axis
makes it suitable for measuring motion status in the human gait.
By attaching these accelerometers to the lower limbs, the velocity
of the feet or legs during the gait can be determined in order to
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Gait Disorders in Parkinson’s Disease 191based on the concept of measuring the rotational inertia, which
can be applied to measure the angular velocity of the feet or legs
while walking and to determine the reorganization of the various
gait phases. During gait analysis, a gyroscope is often combined
with an accelerometer to construct a complete inertial sensing
system.
Compared to a motion-capture system, accelerometers have
certain limitations: they measure acceleration but are poor at
computing the precise position because of the problems of inte-
grating data with baseline drift. The determination of the orienta-
tion of an accelerometer system in an inertial frame is difﬁcult, and
it limits the application of this technique for calculation of joint
kinetics.
Force-plate sensors can be embedded into footwear for ambu-
latory measurement of gait, allowing the capture and analysis of
the gait over long periods of time and while the patient is in a
natural (noncontrolled) environment.
Quantitative ambulatory assessment tools, in combination with
sophisticated analysis software, may pave the way to successful
measurement of gait rhythmicity, stride time variability, and the
coordination during turning. Overall, the advantages of thismethod
over laboratory-based techniques are that it can more readily be
applied to large cohorts and that it can be integrated into a spec-
trum of ecologically relevant tasks that an individual may
encounter in daily life.
4. Current evidence on gait analysis in PD
Quantitative gait assessment tools have been shown to differ-
entiate PD patients from controls; many also track disease pro-
gression and are apparently sensitive to dopaminergic treatment.
PD patients who were off dopaminergic therapy walked more
slowly and with shorter stride length, comparable cadence, and
longer double support times than healthy control subjects7. Hence,
these parameters could be used to monitor treatment response of
gait disorders in PD.
Owing to the episodic and unpredictable nature of FOG, it is
notoriously difﬁcult to study in the laboratory. Patients with FOG
have a higher temporal variability and asymmetry of strides
compared to patients without FOG8. Analysis during a FOG episode
shows that the stepping rhythm suddenly jumps into high fre-
quency (4e5 Hz), and that ﬂoor reaction forces are dysregulated9.
A previous study using wireless portable sensors showed the
feasibility of discriminating FOG from locomotion or volitional
standing by using the frequency spectra of shank vertical linear
acceleration10. In themild form of FOG, it was described as “forward
shufﬂing with small steps” because the foot was still moving for-
ward at the time of initial contact. More severe cases were
accompanied by high-frequency components in the 3e8-Hz band
of vertical leg movement, a reﬂection of the “trembling in place”
observed during FOG. In the most severe cases, patients cannot
move forward at all.
Time-frequency analysis has been reported to be an appropriate
approach to detect brief and subtle FOG episodes in patients with
PD. Before the FOG episode occurs, there is an increase in the
dominant frequency in the 0e3-Hz band (festination), followed by
decreased power in the 0e3-Hz band and increased power in the
3e8-Hz band during the FOG episode. This approach detected even
very brief FOG with acceptable sensitivity (75e83%) and speciﬁcity
(>95%)11.
A comparison study of the clinical and objective measures of
FOG in PD showed that “percent time FOG”, deﬁned as cumulative
duration of FOG/total duration of the walking task, is a more reli-
able metric of severity than the number of freezing events for both
clinical and objective measures.12 Owing to the large degree ofvariability introduced by clinicians, clinical ratings should be used
with caution.
5. Current evidence on treatment of gait disorders in PD
A recent study showed that dopaminergicmedications and deep
brain stimulation surgery provided similar improvements in bal-
ance and gait tasks13. Lack of synergistic effect of these treatments
suggests that both therapies improve balance and gait by inﬂu-
encing similar neural pathways. Levodopa decreased gait variability
and had positive effects on gait stability in persons with PD. PD-
related gait problems may also be managed using varieties of
nonpharmacological therapies14e21. A twice weekly progressive
resistance training program for 10 weeks appeared to be effective
to improve balance and gait function (initial stride length and
velocity) in people with PD14. Rehabilitation program of robot-
assisted gait training was probably more effective than conven-
tional physiotherapy to improve walking speed, and beneﬁts are
maintained for a month15. In a randomized, double-blind, sham-
controlled study, Benninger et al found that 50-Hz repetitive
transcranial magnetic stimulation of the motor cortices in eight
sessions over 2 weeks appeared a short-lived “on”-state improve-
ment in activities of daily living but failed to improve motor per-
formance and functional status for the long run16. In another study,
transcranial direct-current stimulation of the motor and prefrontal
cortices improved gait in PD by somemeasures for a short time and
improved bradykinesia in both the on and off states for longer than
3 months17. In a small case series study, electroconvulsive therapy
was reported a safe and effective therapeutic option in L-dopa-
resistant patients with PD with predominantly axial “on” phe-
nomena18. In a Cochrane Systematic Review published in 2010,
patients with PD who received treadmill training were more likely
to improve their impaired gait in gait speed, stride length, and
walking distance, but not gait cadence. However, it was not known
how long such improvements last19. From tango to tai chi, training
appeared to reduce balance impairments in patients with PD, with
probable additional beneﬁts of improved functional capacity and
reduced falls20,21.
Assistive devices that help patients with PD to remain ambu-
latory and prevent falls include wheeled walkers and specialized
canes22,23. While a cane or a wheeled walker may stabilize patients
and increase conﬁdence, patients immediately walk with a slower
gait and shorter stride length when walking with a wheeled
walker24, suggesting that these ambulatory assistive devices should
be used with caution in clinical practice for gait rehabilitation.
6. Treatment of FOG
FOG is a heterogeneous symptom that can be divided into
dopaminergic-sensitive, dopaminergic-resistant, and dopami-
nergic drug-provoked categories. For patients with dopaminergic-
resistant FOG, other therapeutic options might be considered.
Medications classiﬁed as IA by level of evidence showing clinical
beneﬁt to FOG include levodopa, dopamine agonists, and mono-
amine oxidase type B inhibitors25. The use of methylphenidate for
gait impairment in PD remains controversial26,27. A preliminary
study showed that intravenous amantadinemay be effective in FOG
that is resistant to dopaminergic drugs, suggesting that amantadine
may exert its beneﬁt independent of a dopaminergic mechanism28.
The most well-known nonpharmacological and nonsurgical
treatment of FOG is the use of cueing strategies, which involve the
use of external temporal or spatial stimuli to facilitate movement.
External visual, auditory, or somatosensory cues improve gait in
people with PD, even among drug-naïve patients29. Attentional
strategies include instructions to take big steps and offer an
P.-H. Chen et al.192alternative to external cues; they rely more on cognitive mecha-
nisms of motor control and are internally generated.
During motor planning, cues are believed to activate the pre-
motor cortex, which is followed by suppression of pathological
activity in the subthalamic nuclei, leading to improved motor
performance in PD30. FOG signiﬁcantly improved in PD patients
with both visual and auditory cues, with more beneﬁt from visual
cues31. A recent study has shown that visual cues are beneﬁcial only
when the lower limbs can be seen, suggesting that these cues focus
attention on the lower limbs to compensate for a proprioceptive
processing deﬁcit in PD32. An open-label study also provided evi-
dence of the ability of a laser light visual cue to overcome FOG and
reduce falls in PD patients33.
Auditory cues target not only dopaminergic gait dysfunction
(stride length), but also stride-to-stride ﬂuctuations in gait,
potentially increasing mobility and reducing gait instability and
falls34. The Apple iPod-Shufﬂe has been reported to be a cost-
effective and an innovative platform for the integration of indi-
vidual auditory cueing devices into clinical, social, and home en-
vironments and has been shown to have an immediate effect on
gait, with improvements in walking speed, stride length, and
freezing35.
Persons with PD appear to have been able to beneﬁt from
attentional cues and to combine attentional and auditory cues, but
they did not derive additional beneﬁt from such a combination36. In
more complicated environments, paying attention to cueing might
adversely affect gait; for example, when a simultaneous taskdsuch
as avoiding obstaclesdmust be executed37. In the above studies,
external cueing appears to improve walking under both single- and
dual-task conditions in people with PD. Attentional cues can also
improve walking in people with PD, but controversies still exist
regarding the efﬁcacy of cognitive strategies to improve dual-task
walking.
7. Prognosis and future perspectives
Understanding how gait is inﬂuenced by PD is perhaps the most
important task before us. A major challenge ahead is that gait
analysis remains an academic discipline with little acceptance by
clinicians. Advances in the gait analysis technology will hopefully
bring a decrease in the cost and also facilitate improvements in the
intelligent gait analysis system, which integrates multiple wearable
sensors with small volumes, low power, and wireless data transfer.
In the prospective smart home, gait analysis using wearable sensors
can play an important role as a medical tool for the prevention and
treatment of gait disorders. Further work regarding walking aids
and cueing apparatus is required to determine the most effective
devices in the community setting.
8. Conclusion
Gait should be assessed in every PD patient as part of a basic
evaluation at initial and follow-up examinations. An individualized
approach is needed in all cases to identify problems and determine
a treatment plan. Gait is best managed with a multidisciplinary
team of physical therapists, occupational therapists, gerontologists,
neurologists, and psychologists. Effective treatmentmay reduce the
need for medications and improve the quality of life. Studies of cue
strategies vary in terms of cueing modality, training duration, tests
used for outcome assessment, and duration of follow-up. Currently,
intervention results in beneﬁt to most outcomes over the short
term. Future research is warranted to determine the strategies that
provide the greatest and most sustained beneﬁts for gait distur-
bance in PD.References
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